Go to deals
Private Equity | Food & Beverage

Nazca Capital has acquired Laboratorios Almond

The Spanish private equity fund Nazca Capital S.G.E.I.C., S.A. has acquired Laboratorios Almond, S.L.

Founded in 2001, Nazca Capital focuses on investments in Spanish SMEs. The entry of Nazca into Laboratorios Almond’s share capital aims to consolidate the company’s position as a strategic supplier of ecological and healthy food, both in Spain throughout Europe.

Laboratorios Almond manufactures and supplies organic and bio food products (mainly vegetable-based beverages and desserts, agave syrup, raw sugar cane and coconut oil) under the brand Naturgreen via mass distribution and specialized distribution channels. In addition, Laboratorios Almond has a 50% stake in Nutriops, a company specialized in the commercialization of organic vegetable-based beverages (almond and coconut milk and vegetable creams, among others) under the brand Ecomil, aimed at international markets, with a significant presence in France and other Central European markets.

Oaklins’ team in Spain acted as advisor to the buyer in this transaction.

Parties

Talk to the deal team

Bosco Salaverri Aguilar

Partner
Madrid, Spain
Oaklins SOCIOS

Laura Satrústegui

Partner
Madrid, Spain
Oaklins SOCIOS

Related deals

ELSA Group has sold SoFine Foods to The New Originals Company
Food & Beverage

ELSA Group has sold SoFine Foods to The New Originals Company

The New Originals Company has acquired SoFine Foods from the ELSA Group.

Learn more
Den Berk Délice accelerates growth through strategic partnership
Private Equity | Agriculture

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Learn more
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Healthcare

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Learn more